Altium Capital Management LP Palisade Bio, Inc. Transaction History

Altium Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.11 - $83.85 $620,730 - $473 Million	5,643,007 New	5,643,007 $559,000
Q1 2022 May 16, 2022	SELL	$0.81 - $1.51 $270,502 - $504,270	-333,954 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.3 - $2.96 $434,140 - $988,503	333,954 New	333,954 $434,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.93 $4.29 Million - $7.17 Million	-1,824,894 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.49 - $11.34 $6.37 Million - $20.7 Million	1,824,894 New	1,824,894 $7.43 Million

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $122M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.